Apixaban, a pyrazolopyridine compound, is an oral, direct, and highly selective factor Xa (FXa) inhibitor (Table 1) of both free and bound FXa, as well as of prothrombinase, and is independent of antithrombin III for the prevention and treatment of thromboembolic diseases [99]. Here, F10 is linked to Thromboembolism.